- US Capital Global Securities Launches $10MM Convertible Preferred Stock Offering for Cardax, Inc.
- Conformis, Inc. to Participate in the 32nd Annual Piper Sandler Healthcare Conference
- Cytokinetics to Participate in Upcoming Investor Conferences
- InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein
- Lumos Pharma to Participate in December Investor Conferences
- CytoDyn Announces Partnership with amfAR to Accelerate HIV Cure Research
- Adverum Biotechnologies Presents at the Piper Sandler Annual Virtual Healthcare Conference
- Neoleukin Therapeutics Announces Participation in Piper Sandler 32nd Annual Virtual Healthcare Conference
- Teneobio Announces Poseida’s Exercise of Four Commercial License Options for UniDabs to Targets for Advanced CAR T-cell Therapies
- Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
